Canine Antibodies With Modified Ch2-Ch3 Sequences

text
October 26, 2016

Inventors

Mohamad Morsey, Yuanzheng Zhang, Ian Tarpey

Assignees

  1. Intervet International BV

Abstract

The present invention discloses caninized antibodies with specific properties. The present invention also discloses caninized murine antibodies againstcanine PD-1 that have a high binding affinity for canine PD-1. The invention further discloses the use of the caninized antibodies of the present invention in the treatment of cancer in dogs.

Contact our Scientific Team to Start the Conversation

Request A Call
Back
Categories : Patents
text
PREVIOUS : Antibodies to Canine Interleukin-4 Receptor Alpha
NEXT : Anti-CD33 Antibodies and Methods of Use Thereof
text